Epidemiology of neoplasms in the practice of Medical Rescue Teams in the northern part of the Lubelskie Voivodeship during the SARS-CoV-2-pandemic — a three-year observation

Łukasz Dudziński, Marcin Glinka, Mariusz Panczyk, Magdalena Kryska, Tomasz Kubiak

Vol 18, No 4 (2022)

Review paper

Uptake of screening mammogram in West Central Illinois during the COVID-19 pandemic: lessons learned

John Owoade Agboola, Oluwasola Stephen Ayosanmi, Oluwatobi Mogbojuri, Maureen Bezold

Vol 18, No 4 (2022)

Research paper

The role of anthracycline and pertuzumab in preoperative treatment of HER2-positive breast cancer

Sylwia Dębska-Szmich, Piotr Potemski

Vol 19, No 1 (2023)

Review paper

Sacituzumab govitecan — a new therapy for patients with triple-negative breast cancer

Katarzyna Pogoda, Agnieszka Jagiełło-Gruszfeld, Anna Niwińska, Zbigniew Nowecki

Vol 19, No 1 (2023)

Review paper

Epidemiological features and changes in the occurrence of infectious diseases in Poland from 2015 to 2020 in the context of the emerging novel SARS-CoV-2 (COVID-19) pandemic

Aneta Mela, Elżbieta Rdzanek, Łukasz A. Poniatowski, Janusz Jaroszynski, Tomasz Kalicki, Monika M. Dutka, Maciej Furman, Anna Czajka, Marzena Furtak-Niczyporuk, Monika Wojciechowska, Justyna E. Król-Całkowska, Bartłomiej Drop, Katarzyna Drop, Maciej Krzakowski, Magdalena Sakowicz, Bartosz Grucza, Joanna Cygler, Beata Jagielska

Vol 18, No 4 (2022)

Review paper

HER2-low — the new subtype of breast cancer?

Katarzyna Pogoda, Agnieszka Jagiełło-Gruszfeld, Zbigniew Nowecki

Vol 18, No 4 (2022)

Review paper

Radioligand therapy — personalized treatment for patients with neuroendocrine tumors

Agnieszka Kolasińska-Ćwikła

Vol 19, No 2 (2023)

Review paper

The usefulness of the QualityMetric Health Outcomes™ Scoring Software 5.0 for predicting the risk of depression in male partners of cancer patients

Marcin J. Jabłoński, Francisco Garcia-Torres, Paulina Zielińska, Alicja Bułat, Piotr Brandys, Marzena Samardakiewicz

Vol 18, No 4 (2022)

Review paper

Cisplatin — properties and clinical application

Anna Kopacz-Bednarska, Teodora Król

Vol 18, No 3 (2022)

Review paper

Commentary to Effect of ribociclib plus fulvestrant on overall survival in the treatment of advanced breast cancer — updated MONALEESA-3 results

Barbara Radecka

Vol 18, No 3 (2022)

Commentary

Effect of ribociclib plus fulvestrant on overall survival in the treatment of advanced breast cancer — updated MONALEESA-3 results

Roman Dubiański

Vol 18, No 3 (2022)

Review paper

The rehabilitation of cancer patients and the role of nurses: a scoping review

Catarina Rodrigues, Bárbara Gomes, Carlos Albuquerque

Vol 18, No 3 (2022)

Review paper

Different MET gene alterations in lung adenocarcinoma patients

Paulina Terlecka, Paweł Krawczyk, Kamila Wojas-Krawczyk, Anna Grenda, Izabela Chmielewska, Robert Kieszko, Artur Bartczak, Janusz Milanowski

Vol 18, No 3 (2022)

Research paper

Expert recommendation on diagnostic-therapeutic management in skin carcinomas

Piotr Rutkowski, Witold Owczarek, Dariusz Nejc, Arkadiusz Jeziorski, Wojciech M. Wysocki, Monika Słowińska, Monika Dudzisz-Śledź, Piotr Wiśniewski, Hanna Tchórzewska-Korba, Anna Szumera-Ciećkiewicz, Hanna Koseła-Paterczyk, Dorota Kiprian, Tomasz Świtaj, Joanna Narbutt, Leszek Królicki, Dawid Murawa, Marcin Zdziniecki, Marcin Ziętek, Adam Maciejczyk, Lidia Rudnicka

Vol 18, No 2 (2022)

Guidelines / Expert consensus

Supportive activities in oncological wards during the COVID-19 pandemic: a qualitative study

Mahdieh Poodineh Moghadam, Ahmad Nasiri, Gholamhossein Mahmoudirad

Vol 19, No 1 (2023)

Research paper

Long-term overall survival in a patient with non-small cell lung cancer with KRAS mutation

Izabela Chmielewska

Vol 19, No 2 (2023)

Case report

Benefits of β-blockers in cancer treatment

Mohamad Arif, Mardiah Suci Hardianti, Nurina Tyagita, Azizah Hikma Safitri

Vol 19, No 2 (2023)

Review paper

Stevens-Johnson syndrome in breast cancer patient treated with ribociclib

Adam Kowalczyk, Barbara Radecka

Vol 19, No 1 (2023)

Case report

Resistance to neoadjuvant chemotherapy in breast cancer with proven intratumoral heterogeneity: a clinical case

Vasil D. Nanev, Silvia V. Naneva, Angel D. Yordanov, Strahil A. Strashilov, Ivan N. Ivanov

Vol 18, No 2 (2022)

Case report

Evolution of prostate cancer therapy. Part 1

Paweł M. Potocki, Piotr J. Wysocki

Vol 18, No 3 (2022)

Review paper

What is new about germ cell ovarian tumors?

Izabela Pilarska, Kinga Grabska, Marta Fudalej, Andrzej Deptała, Anna Badowska-Kozakiewicz

Vol 18, No 2 (2022)

Review paper

Grief reactions of family members after the death of cancer patients: a phenomenological study

Mahnaz Ghaljeh, Marjan Mardani-Hamooleh, Nasrin Rezaee

Vol 18, No 2 (2022)

Research paper

Immune checkpoint inhibitors in the first-line treatment of metastatic small-cell lung cancer

Magdalena Knetki-Wróblewska, Dariusz M. Kowalski, Maciej Krzakowski

Vol 18, No 2 (2022)

Review paper

Immunotherapy with pembrolizumab in a patient with advanced non-small-cell lung cancer with high PD-L1 expression and MET exon 14 splice site mutation

Paulina Terlecka, Paweł Krawczyk, Anna Grenda, Izabela Chmielewska, Janusz Milanowski

Vol 19, No 1 (2023)

Case report

Microwave ablation of colorectal cancer lung metastases — the first experience in Poland

Grzegorz Rosiak, Maciej Krzakowski, Krzysztof Milczarek, Dariusz Konecki, Olgierd Rowiński

Vol 19, No 2 (2023)

Research paper